Lilly Completes Acquisition of Point Biopharma
Eli Lilly and Company (NYSE: LLY) acquired POINT Biopharma Global Inc. (NASDAQ: PNT), a radiopharmaceutical company with a pipeline of clinical and preclinical-stage radioligand therapies
An Eco-System for Startups
Eli Lilly and Company (NYSE: LLY) acquired POINT Biopharma Global Inc. (NASDAQ: PNT), a radiopharmaceutical company with a pipeline of clinical and preclinical-stage radioligand therapies
91. Kedar Apte Company – bp Kedar Apte is the Chief Marketing Officer at bp. He is a business professional with 20 years
Hurr, a London, UK-based fashion rental platform, raised $10M (£7.9M) in funding to date. The latest round included participation from Praetura Ventures (lead), and
Metrion Biosciences, a Cambridge, UK-based ion channel CRO and drug discovery company, raised £3.7M in funding. The round was led by Maven
Peach Worlds, a London, UK-based provider of a a no-code builder for 3D Immersive Websites, raised USD$540K in Pre-Seed funding. The round
Labrys Technologies, a London UK-based defence technology startup, raised $5.5M in Seed funding. The round was led by Project A Ventures, with
Lyndra Therapeutics, a Watertown, MA-based clinical-stage biopharmaceutical company, raised $101M in Series E funding. The round was led by Sarissa Capital and
Cart.com, an Austin, TX-based provider of unified commerce and logistics solutions, received $30M growth capital from Trinity Capital (NASDAQ: TRIN). The company intends
Pluristyx, a Seattle, WA-based provider of tools, technologies and services for the development of cell therapies, raised a major fundraising. The round
Nexus Development Capital, a provider of catalytic capital for sustainable infrastructure project developers, made a $5M investment in Portland, ME-based biochar producer Standard Biocarbon. The funding